MENU
DEC 03, 2020 6:00 AM PST

Keynote Presentation: Facial Masking for COVID-19: Transmission, Severity and Immunity

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Professor of Medicine and Associate Chief, Division of HIV, Infectious Diseases, and Global Medicine, UCSF, Director, UCSF-Gladstone Center for AIDS Research (CFAR)
    Biography

      Monica Gandhi MD, MPH is an Infectious Diseases doctor, Professor of Medicine and Associate Chief in the Division of HIV, Infectious Diseases, and Global Medicine at the University of California, San Francisco (UCSF). She is also the Director of the UCSF Center for AIDS Research (CFAR) and the Medical Director of the HIV Clinic ("Ward 86") at San Francisco General Hospital. Her research focuses on HIV and women and adherence measurement in HIV treatment and prevention and most recently, on how to mitigate the COVID-19 pandemic.


    Abstract

    This talk goes over the importance of face masks as a pillar of COVID-19 pandemic control. First, we review the epidemiologic evidence for how face masks reduce COVID-19 transmission from studies in the United States since the beginning of the pandemic.  We then discuss an emerging hypothesis that viral inoculum or dose is related to severity of disease so that face masks may also increase the proportion of asymptomatic infection (if infection occurs) by reducing viral dose. Finally this talk discusses the physical science properties of masks and makes recommendations for basic and maximal protection masks for the public.

    Learning Objectives:

    1. To review the epidemiologic data on how face masks reduce COVID-19 transmission

    2. To explore the hypothesis that reducing the viral inoculum (via face masks) will lead to less severe disease if infected

    3. To review the type of face masks most protective for the public


    Show Resources
    You May Also Like
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 17, 2020 2:00 PM PDT
    C.E. CREDITS
    SEP 17, 2020 2:00 PM PDT
    Learning Objectives: 1. Understanding the integral value of collaboration for advancement in scientific research; how to establish and grow academic, Pharma, and industry connections 2. Lear...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    C.E. CREDITS
    Antibody tests are important tools to assess the efficacy of vaccine candidates and to derive suitable vaccination modalities. High specificity and sensitivity are of great importance for th...
    Loading Comments...
    Show Resources
    Attendees
    • See more